Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
- PMID: 15541308
- DOI: 10.1016/j.neuron.2004.10.023
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
Abstract
Parkinson's disease (PD; OMIM #168600) is the second most common neurodegenerative disorder in the Western world and presents as a progressive movement disorder. The hallmark pathological features of PD are loss of dopaminergic neurons from the substantia nigra and neuronal intracellular Lewy body inclusions. Parkinsonism is typically sporadic in nature; however, several rare familial forms are linked to genetic loci, and the identification of causal mutations has provided insight into the disease process. PARK8, identified in 2002 by Funayama and colleagues, appears to be a common cause of familial PD. We describe here the cloning of a novel gene that contains missense mutations segregating with PARK8-linked PD in five families from England and Spain. Because of the tremor observed in PD and because a number of the families are of Basque descent, we have named this protein dardarin, derived from the Basque word dardara, meaning tremor.
Comment in
-
Protein kinases linked to the pathogenesis of Parkinson's disease.Neuron. 2004 Nov 18;44(4):575-7. doi: 10.1016/j.neuron.2004.11.008. Neuron. 2004. PMID: 15541303
Similar articles
-
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.Brain. 2005 Dec;128(Pt 12):2786-96. doi: 10.1093/brain/awh667. Epub 2005 Nov 4. Brain. 2005. PMID: 16272164
-
Familial Parkinson's disease: clinical and genetic analysis of four Basque families.Ann Neurol. 2005 Mar;57(3):365-72. doi: 10.1002/ana.20391. Ann Neurol. 2005. PMID: 15732106
-
Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.Neuron. 2004 Nov 18;44(4):601-7. doi: 10.1016/j.neuron.2004.11.005. Neuron. 2004. PMID: 15541309
-
[Clinical molecular genetics for PARK8 (LRRK2)].Brain Nerve. 2007 Aug;59(8):839-50. Brain Nerve. 2007. PMID: 17713120 Review. Japanese.
-
α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease.Neurotoxicology. 2011 Oct;32(5):622-9. doi: 10.1016/j.neuro.2011.01.003. Epub 2011 Jan 14. Neurotoxicology. 2011. PMID: 21238487 Free PMC article. Review.
Cited by
-
Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway.Mol Neurodegener. 2012 Jan 9;7:2. doi: 10.1186/1750-1326-7-2. Mol Neurodegener. 2012. PMID: 22230652 Free PMC article.
-
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.EMBO J. 2012 Jun 26;31(14):3038-62. doi: 10.1038/emboj.2012.170. EMBO J. 2012. PMID: 22735187 Free PMC article. Review.
-
The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease.Biomolecules. 2020 Jun 16;10(6):912. doi: 10.3390/biom10060912. Biomolecules. 2020. PMID: 32560161 Free PMC article. Review.
-
Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased risk.Front Neurol. 2022 Oct 26;13:1016040. doi: 10.3389/fneur.2022.1016040. eCollection 2022. Front Neurol. 2022. PMID: 36388213 Free PMC article. No abstract available.
-
Application of next-generation sequencing technologies in Neurology.Ann Transl Med. 2014 Dec;2(12):125. doi: 10.3978/j.issn.2305-5839.2014.11.11. Ann Transl Med. 2014. PMID: 25568878 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases